125 related articles for article (PubMed ID: 4590293)
1. Immunosuppressive effects of an interferon preparation in vivo.
Hirsch MS; Ellis DA; Black PH; Monaco AP; Wood ML
Transplantation; 1974 Feb; 17(2):234-6. PubMed ID: 4590293
[No Abstract] [Full Text] [Related]
2. [Effect of exogenous interferon on the transplantation reactions of mice].
Ogurtsov RP; Zheleznikova GF
Zh Mikrobiol Epidemiol Immunobiol; 1978 Mar; (3):45-50. PubMed ID: 352057
[TBL] [Abstract][Full Text] [Related]
3. [Prolongation, by interferon, of the survival of skin grafts in the mouse].
de Maeyer E; Mobraaten L; de Maeyer-Guignard J
C R Acad Hebd Seances Acad Sci D; 1973 Nov; 277(19):2101-3. PubMed ID: 4208698
[No Abstract] [Full Text] [Related]
4. Stimulation of transplantation immunity and plasma cell reaction by interferon in mice.
Skurkovich SV; Klinova EG; Aleksandrovskaya IM; Levina NV; Arkhipova NA; Bulicheva TI
Immunology; 1973 Aug; 25(2):317-22. PubMed ID: 4354827
[TBL] [Abstract][Full Text] [Related]
5. "In vivo" standardization model for defining the dose-response-dependent graft-protective value of antilymphocyte sera.
Réthy L; Osz E
Dev Biol Stand; 1974; 27():233-5. PubMed ID: 4618536
[No Abstract] [Full Text] [Related]
6. Survival of first and second-set skin allografts in mice and rats under the influence of cysteine.
Ryzewski J; Kossakowska M
Arch Immunol Ther Exp (Warsz); 1974; 22(5):625-8. PubMed ID: 4614758
[No Abstract] [Full Text] [Related]
7. Leukemia virus activation during homograft rejection.
Hirsch MS; Ellis DA; Black PH; Monaco AP; Wood ML
Science; 1973 May; 180(4085):500-2. PubMed ID: 4349511
[TBL] [Abstract][Full Text] [Related]
8. A novel series of low molecular weight immunosuppressive agents.
Ocain TD; Bastos CM; Gordon KA; Granstein RD; Jenson JC; Jones B; McAuliffe DJ; Newcomb JR
Transplant Proc; 1996 Dec; 28(6):3032-4. PubMed ID: 8962176
[No Abstract] [Full Text] [Related]
9. In vivo effects of cyclomunine on murine skin graft rejection.
Kaiserlian D; Simon-Lavoine N
Transplantation; 1982 Mar; 33(3):314-6. PubMed ID: 7039038
[No Abstract] [Full Text] [Related]
10. In vivo immunosuppression with lymphocyte chalone.
Lilly JR; Houck JC
Surg Forum; 1973; 24():339-40. PubMed ID: 4282524
[No Abstract] [Full Text] [Related]
11. Immunosuppressive effect of stepronin (TS-5010680) in mice.
de Giorgi L; Arrigoni-Martelli E; Matossian-Rogers A
Transplant Proc; 1994 Dec; 26(6):3513-6. PubMed ID: 7998255
[No Abstract] [Full Text] [Related]
12. [Stimulation of transplantation immunity and the plasmacyte reaction in mice by interferon].
Skurkovich SV; Klinova EG; Aleksandrovskaia IM; Levina NV; Arkhipova NA
Biull Eksp Biol Med; 1973 Apr; 75(4):66-9. PubMed ID: 4614874
[No Abstract] [Full Text] [Related]
13. Letter: Immunosuppressive properties of the lymphocyte chalone.
Houck JC; Attallah AM; Lilly JR
Nature; 1973 Sep; 245(5421):148-50. PubMed ID: 4270300
[No Abstract] [Full Text] [Related]
14. Activation of C-type viruses during skin graft rejection in the mouse. Interrelationships between immunostimulation and immunosuppression.
Hirsch MS; Ellis DA; Kelly AP; Proffitt MR; Black PH; Monaco AP; Wood ML
Int J Cancer; 1975 Mar; 15(3):493-502. PubMed ID: 166935
[TBL] [Abstract][Full Text] [Related]
15. Failure to increase the in vivo immunosuppressive activity of antilymphocyte globulin by conjugation with melphalan.
Brent L; Horsburgh T; Rowland G; Wood P
Transplantation; 1980 Apr; 29(4):280-82. PubMed ID: 6989047
[TBL] [Abstract][Full Text] [Related]
16. Specific unresponsiveness to skin allografts in mice. I. Properties of tissue extracts and their synergistic effect with antilymphocytic serum.
Brent L; Hansen JA; Kilshaw PJ; Thomas AV
Transplantation; 1973 Jan; 15(1):160-71. PubMed ID: 4575919
[No Abstract] [Full Text] [Related]
17. An active suppressor mechanism preventing skin allograft rejection in mice.
Kilshaw PJ; Brent L; Pinto M
Transplant Proc; 1975 Jun; 7(2):225-8. PubMed ID: 48301
[No Abstract] [Full Text] [Related]
18. Mechanism of the suppressive effect of interferon on antibody synthesis in vivo.
Brodeur BR; Merigan TC
J Immunol; 1975 Apr; 114(4):1323-8. PubMed ID: 163863
[TBL] [Abstract][Full Text] [Related]
19. Desferrioxamine treatment prevents chronic islet allograft damage.
Bradley B; Prowse SJ; Bauling P; Lafferty KJ
Diabetes; 1986 May; 35(5):550-5. PubMed ID: 3082702
[TBL] [Abstract][Full Text] [Related]
20. Interferon: a perspective.
Weissman RM; Droller MJ
Invest Urol; 1980 Nov; 18(3):189-96. PubMed ID: 6159334
[No Abstract] [Full Text] [Related]
[Next] [New Search]
